Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Athira Pharma Q1 EPS $(0.56) Down From $(0.25) YoY

Athira Pharma (NASDAQ:ATHA) reported quarterly losses of $(0.56) per share. This is a 124 percent decrease over losses of $(0.25) per share from the same period last year.
byBenzinga Newsdesk
May 12, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Athira Pharma (NASDAQ:ATHA) reported quarterly losses of $(0.56) per share. This is a 124 percent decrease over losses of $(0.25) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Recap: Pentair Q2 Earnings

By Benzinga Insights
Today, 1:11 PM
  Pentair (NYSE:PNR) reported its Q2 earnings results on Tuesday, July 26, 2022 at 06:55 AM. Here's what investors need to know about the announcement. Earnings Pentair beat estimated earnings by 2.0%, reporting an EPS of $1.02 versus an estimate of $1.0.

PNR